Certara (Biosimulation)

Radnor, PA · United States

Contract Research Organizationmid

Specialization: MIDD / Pharmacometrics

Key Differentiator

NASDAQ: CERT; Simcyp = industry standard PBPK (EMA-qualified Aug 2025); Phoenix = #1 PK/PD platform; 11 regulators use Certara tools; 11 scientists on Stanford/Elsevier Top 2% list

Core Services

Pharmacometrics (popPK, PKPD, exposure-response), PBPK modeling (Simcyp), Phoenix PK/PD platform, trial simulation, virtual bioequivalence, QSP modeling, clinical pharmacology consulting

Capabilities

Pharmacometrics (popPKPKPDexposure response)PBPK modeling (Simcyp)Phoenix PK/PD platformtrial simulationvirtual bioequivalenceQSP modelingclinical pharmacology consulting

Market Intelligence

Biosimulation market: $4.09B (2025) → $19.49B (2035), CAGR 16.9%; services fastest-growing segment

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.